首页 理论教育 危险因素的处理

危险因素的处理

时间:2022-03-18 理论教育 版权反馈
【摘要】:吸烟可诱发或加重血管内皮功能异常,促进凝血,诱发氧化应激,干扰脂蛋白代谢,加重炎症反应和胰岛素抵抗,增加冠心病死亡率。所以,所有冠心病患者都应戒烟。研究表明,超过2/3的冠心病患者存在糖代谢异常,除显性糖尿病外,糖耐量减低、空腹血糖异常均增加冠心病患者的事件发生率,影响其预后,应给予相应的关注和处理。

(一)吸烟

吸烟可诱发或加重血管内皮功能异常,促进凝血,诱发氧化应激,干扰脂蛋白代谢,加重炎症反应和胰岛素抵抗,增加冠心病死亡率。所以,所有冠心病患者都应戒烟。

(二)高血压

通过药物与非药物干预,将患者血压降至140/90mmHg以下,有心肌梗死病史、合并糖尿病、慢性肾病和脑卒中史者降至130/80mmHg以下。选择降压药物时,应优先考虑β受体阻滞药和ACEI。

(三)糖代谢异常

研究表明,超过2/3的冠心病患者存在糖代谢异常,除显性糖尿病外,糖耐量减低、空腹血糖异常均增加冠心病患者的事件发生率,影响其预后,应给予相应的关注和处理。

(宋尚明)

参考文献

[1]中华医学会心血管病分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断和治疗指南.中华心血管病杂志,2007,35(3):195-206.

[2]Fraker TD Jr,Fihn SD,Gibbons RJ,et al.2007 chronic angina focused update of the ACC/AHA 2002Guidelines for the management of patients with chronic stable angina:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002Guidelines for the management of patients with chronic stable angina.Circulation,2007,116(23):2762-2772.

[3]Fox K,Garcia MA,Ardissino D,et al.Guidelines on the management of stable angina pectoris:executive summary:The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.Eur Heart J,2006,27(11):1341-1381.

[4]Campeau L.Letter:Grading of angina pectoris.Circulation,1976,54(3):522-523.

[5]Fletcher GF,Flipse TR,Kligfield P,et al.Current status of ECG stress testing.Curr Probl Cardiol,1998,23:353-423.

[6]Ben-Dor I,Battler A.Treatment of stable angina.Heart,2007,93(7):868-874.

[7]Antman EM,Wiviott SD,Murphy SA,et al.Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention:a TRITON-TIMI 38(TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction)analysis.J Am Coll Cardiol,2008,51(21):2028-2033.

[8]Freemantle N,Urdahl H,Eastaugh J,et al.What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function?Evidence and(mis)interpretation.Prog Cardiovasc Dis,2002,44(4):243-250.

[9]Dagenais GR,Pogue J,Fox K,et al.Angiotensinconverting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure:a combined analysis of three trials.Lancet,2006,368(9535):581-588.

[10]Nash DT,Nash SD.Ranolazine for chronic stable angina.Lancet,2008,372(9646):1335-1341.

免责声明:以上内容源自网络,版权归原作者所有,如有侵犯您的原创版权请告知,我们将尽快删除相关内容。

我要反馈